Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 3019-3023

  Biesterfeld, Stefan ^a   Josef, Juliana ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Computer assisted; Differential diagnosis; Image analysis; Immunohistochemistry; Immunohistometry; Keratoacanthoma; MIB 1; Skin diseases; Skin neoplasms; Squamous cell carcinoma

Indexed keywords

FORMALDEHYDE; MONOCLONAL ANTIBODY KI 67; PARAFFIN; PEROXIDASE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TECHNIQUE; TELEVISION; TISSUE SECTION;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; KI-67 ANTIGEN; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0036766033     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hutchinson J: Morbid growths and tumours. 1. The "crateriform ulcer of the face", a form of acute epithelial cancer. Trans Pathol Soc London 40: 275-281, 1889.
2. Rook A and Whimster IW: Le keratoacanthome. Arch Bel Dermatol Syphilol 6: 137-146, 1950.
3. Hodak E, Jones RE and Ackerman AB: Solitary keratoacanthoma is a squamous-cell carcinoma: Three examples with metastases. Am J Dermatopathol 15: 332-342, 1993.
4. Ackerman AB: Differential Diagnosis in Dermatopathology, Vol. 1, Lea & Febiger, Philadelphia, USA, 1982.
5. Schwartz RA: Keratoacanthoma. J Am Acad Dermatol 30: 1-19, 1994.
6. Manstein CH, Frauenhoffer CJ and Besden JE: Keratoacanthoma: Is it a real entity? Ann Plast Surg 40: 469-472, 1998.
7. De Morgas JM, Winbkelmann RK and Jordan RE: Immunoflourescence of epithelial skin tumors. I. Patterns of intracellular substance. Cancer 25: 1399-1403, 1970.
8. Schaumburg-Lever G, Alroy J, Garvis V, Ucci A and Lever WF: Cell surface carbohydrates in proliferative epidermal lesions. Am J Dermatopathol 6: 583-589, 1984.
9. Markey AC, Churchill AJ and Mac Donald DM: Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumors. J Cutan Pathol 17: 65-71, 1990.
10. Kanitakis J, Hoyo E, Hermier C, Chouvet B and Thivolet J: Nucleolar organizer region enumeration in keratoakanthomas and squamous cell carcinomas of the skin. Cancer 69: 2938-2941, 1992.
11. Krunic AL, Garrod DR, Madani S, Buchanan MD and Clark RE: Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 77: 1275-1279, 1998.
12. Hsi ED, Svoboda-Newman SM, Stern RA, Nickoloff BJ and Frank TS: Detection of human papillomavirus DNA in keratoacanthomas by polymerase chain reaction. Am J Dermatopathol 19: 10-15, 1997.
13. Stockfleth E, Meinke B, Arndt R, Christophers E and Meyer T: Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients. Dermatology 198: 122-125, 1999.
14. Herzberg AJ, Kerns BJ, Pollack V and Kinney RB: DNA image cytometry of keratoacanthoma and squamous cell carcinoma. Arch Dermatol 127: 1167-1171, 1991.
15. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR and Albino AP: Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 130: 225-232, 1994.
16. Graham RM, Macfarlane AW, Curley RK and Nash JRG: Beta 2 microglobulin expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol 117: 441-449, 1987.
17. Klein-Szanto AJP, Barr RJ, Reiners JJ and Mamrack MD: Filaggrin distribution in keratoacanthoma and squamous cell carcinoma. Arch Pathol Lab Med 108: 888-890, 1984.
18. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab J and Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
19. Bravo R, Frank R, Blundell PA and MacDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 326: 515-517, 1987.
20. Biesterfeld S and Hoffmann E: MIB-1 immunohistometry on Tru-cut biopsies in inflammatory and cirrhotic liver disease. Anal Quant Cytol Histol 20: 268-274, 1998.
21. Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F and Thierauf P: Proliferation parameters for pituitary adenomas. Acta Neurochir 65 (Suppl): 18-21, 1996.
22. Pernicone PJ, Scheithauer BW, Sebo RJ, Kovacs KT, Horvath E, Young WF Jr, Lloyd RV, Davis DH, Guthrie BL and Schoene WC: Pituitary carcinoma. A clinicopathologic study of 15 cases. Cancer 79: 804-812, 1997.
23. Baretton GB, Diebold J, Christoforis G, Wogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M and Löhrs U: Apoptosis and immunohistochemical bcl 2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 77: 255-264, 1996.
24. Resnick MB, Gallinger S, Wang HH and Odze RD: Growth factor expression and proliferation kinetics in periampullary neoplasms in familial adenomatous polyposis. Cancer 76: 187-194, 1995.
25. Yonemura Y, Kimura H, Fushida S, Tugawa K, Nakai Y, Kaji M, Fonseen L, Yamaguchi A and Miyazaki I: Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 71: 2448-2453, 1993.
26. Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T and Tsuneyoshi M: Long term follow up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer 74: 2896-2907, 1994.
27. Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, Kondo Y and Nagao K: Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl. Cancer 82: 439-447, 1998.
28. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawaoi A, Oyama T, Sugai T and Sasou S: Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 26: 139-146, 1995.
29. Shimizu T, Usada N, Yamanda T, Sugenoya A and Lida F: Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer 71: 2807-2812, 1993.
30. Rickert D, Mittermayer C, Lindenfelser R and Biesterfeld S: MIB-1 immunohistometry of follicular tumors of the thyroid gland. Anal Quant Cytol Histol 22: 229-234, 2000.
31. Biesterfeld S, Striepecke E, Manegold E and Handt S: Immunohistometry: An image analytical application for the single-cell based quantification of nuclear immunostaining. Electr J Pathol Histol 1: 954-03, 1995.
32. Matsuta M, Kimura S, Kosegawa G, Kon S and Matsuta M: Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1). J Derm 23: 147-152, 1996.
33. Tsuji T: Keratoacanthoma and squamous cell carcinoma: study of PCNA and LeY expression. J Cutan Pathol 24: 409-415, 1997.
34. Philips P and Helm KF: Proliferating cell nuclear antigen distributionin keratoacanthoma and squamous cell carcinoma. J Cutan Pathol 20: 424-428, 1993.
35. Cain CT, Niemann TH and Argenyi ZB: Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatol 17: 324-331, 1995.
36. Skalova A and Michal M: Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin section. Am J Dermatopathol 17: 332-334, 1995.
37. Sagol O, Kurtoglu B, Ozer E and Pabuccuoglu U: Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas. Gen Diagn Pathol 143: 305-309, 1998.
38. Taylor CR: An exaltation of experts: concerned efforts in the standardization of immunohistochemistry. Hum Pathol 25: 2-11, 1994.
39. McNicol AM and Richmond JA: Optimizing immunohistochemistry: antigen retrieval and signal amplification. Histopathology 32: 97-103, 1998.